4DMedical Ltd.ASX: 4DX

4DMedical gains U.S. CMS reimbursement for CTVQ

· Issued by 4DMedical Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

4DMedical Ltd. announces that the U.S. Centers for Medicare & Medicaid Services has confirmed reimbursement for its CT:VQ technology, which is expected to accelerate market adoption. This development is seen as a significant step towards improving healthcare accessibility and reducing costs for both outpatient and inpatient settings. The company is now positioned to launch CT:VQ commercially across the United States following this confirmation and previous FDA clearance.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases